An update on Kawasaki disease

Autoimmunity Reviews

Volumn 2, Issue 5, 2003, Pages 258-263

  Cimaz, Rolando ^a,c   Falcini, Fernanda ^b  

^a ICP   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c Pediatric Department   (Italy)

Author keywords

Childhood; Kawasaki disease; Vasculitis

Indexed keywords

IMMUNOGLOBULIN;

ARTERY DISEASE; ASIA; BIOAVAILABILITY; CORONARY ARTERY ANEURYSM; DIAGNOSTIC TEST; GENE OVEREXPRESSION; HUMAN; ISCHEMIC HEART DISEASE; MUCOCUTANEOUS LYMPH NODE SYNDROME; REDUCTION; REVIEW; RISK FACTOR; SYSTEMIC VASCULITIS;

CHILD; DIAGNOSIS, DIFFERENTIAL; HEART DISEASES; HUMANS; INFANT; MUCOCUTANEOUS LYMPH NODE SYNDROME; PROGNOSIS;

EID: 0042763095     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1568-9972(03)00032-6     Document Type: Review

References (30)

1. Nakamura Y., Yanagawa H., Harada K., Kato H., Kawasaki T. Mortality among persons with a history of Kawasaki disease in Japan: existence of cardiac sequelae elevated the mortality. J Epidemiol. 10:2000;372-375.
2. Silva A.A., Maeno Y., Hashmi A., Smallhorn J.F., Silverman E.D., McCrindle B. Cardiovascular risk factors after Kawasaki disease: a case-control study. J Pediatr. 138:2001;400-405.
3. Council on cardiovascular disease in the young, committee on rheumatic fever, endocarditis and Kawasaki disease. American Heart Association. Diagnostic guidelines for Kawasaki disease. Circulation 2001;103:335-336.
4. Taubert K.A. Epidemiology of Kawasaki disease in the United States and worldwide. Prog Pediatr Cardiol. 6:1997;181-185.
5. Harnden A., Alves B., Sheikh A. Rising incidence of Kawasaki disease in England: analysis of hospital admission data. BMJ. 324:2002;1424-1425.
6. Gardner-Medwin J.M.M., Dolezalova P., Cummins C., Southwood T.R. Incidence of Henoch-Schonlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins. Lancet. 360:2002;1197-1202.
7. Falcini F., Cimaz R., Calabri G.B., et al. Kawasaki Disease in Northern Italy: a multicenter data collection of 250 patients. Clin Exp Rheumatol. 20:2002;421-426.
8. Abe J., Kotzin B.L., Judo K., et al. Selctive expansion of T cells expressing T-cell receptor variable regions V beta 2 and V beta 8 in Kawasaki disease. Proc Natl Acad Sci. 89:1992;4066-4070.
9. Abe J., Kotzin B.L., Meissner C., et al. Characterization of T-cell repertoire changes in acute Kawasaki disease. J Exp Med. 177:1993;791-796.
10. Choi I.H., Chwae Y.J., Shim W.S., et al. Clonal expansion of CD8+T cells in Kawasaki disease. J Immunol. 159:1997;481-486.
11. Leung D.Y.M., Meissner H.C., Shulman S.T., et al. Prevalence of superantigen-secreting bacteria in patients with Kawasaki disease. J Pediatr. 140:2002;742-746.
12. Pietra B.A., De Inocencio J., Giannini E.H., Hirsch R. T cell receptor V beta family repertoire and T cell activation markers in Kawasaki disease. J Immunol. 153:1994;1881-1888.
13. Matsuhara T., Farukawa S., Yakuta K. Serum levels of tumor necrosis factor, interleukin 2 receptor, and interferon-gamma in Kawasaki disease involved coronary-artery lesions. Clin Immunol Immunopathol. 56:1990;29-36.
14. Quasney M.W., Bronstein D.E., Cantor R.M., et al. Increased frequency of alleles associated with elevated Tumor Necrosis Factor alpha levels in children with Kawasaki disease. Pediatr Res. 49:2001;686-690.
15. Grunebaum E., Blank M., Cohen S., et al. The role of anti-endothelial cell antibodies in Kawasaki disease - in vitro and in vivo studies. Clin Exp Immunol. 130:2002;233-240.
16. Falcini F., Generini S., Pignone A., et al. Are angiotensin converting enzyme and von Willebrand factor circulating levels useful surrogate parameters to monitor disease activity in Kawasaki disease? Endothelium. 6:1999;209-215.
17. Rowley A.H., Shulman S.T., Spike B.T., Mask C.A., Baker S.C. Oligoclonal IgA response in the vascular wall in acute Kawasaki disease. J Immunol. 166:2001;1334-1343.
18. Tsuda E., Kamiya T., Kimura K., Ono Y., Echigo S. Coronary artery dilatation exceeding 4.0 mm during acute Kawasaki disease predicts a high probability of subsequent late intima-medial thickening. Pediatr Cardiol. 23:2002;9-14.
19. Newburger J.W. Kawasaki disease. Current treatment options. Cardiovasc Med. 2:2000;227-236.
20. Duronpisitkul K., Gururaj V.J., Park J.M., Martin C.F. The prevention of coronary artery aneurysm in Kawasaki disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment. Pediatrics. 96:1995;1057-1061.
21. Terai M., Shulman S.T. Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gammaglobulin dose but independent of salicylate dose. J Pediatr. 131:1997;888-893.
22. Sundel R.P., Burns J.C., Baker A., Beiser A.S., Newburger J.W. γ-globulin retreatment in Kawasaki disease. J Pediatr. 123:1993;657-659.
23. Burns J.C., Capparelli E.V., Brown J.A., Newburger J.W. Intravenous γ-gammaglobulin treatment and retreatment in Kawasaki disease. US/ Canadian Kawasaki disease study group. Pediatr Infect Dis J. 17:1998;478-481.
24. Hashino K., Ishii M., Iemura M., Akagi T., Kato H. Re-treatment for immune globulin - resistant Kawasaki disease. Study of additional immune globulin and steroid pulse therapy. Pediatr Int. 43:2001;211-217.
25. Wright D.A., Newburger J.W., Baker A., Sundel R.P. Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids. J Pediatr. 128:1996;146-149.
26. Shinohara M., Katsuhiko S., Tomomasa T., Morikawa A. Corticosteroids in the treatment of the acute phase of Kawasaki disease. J Pediatr. 135:1999;465-469.
27. Dole R.C., Saleem M.A., Daw S., Dillon M.J. Treatment of severe complicated Kawasaki disease with oral prednisolone and aspirin. J Pediatr. 137:2000;723-726.
28. Oki I., Tanihara S., Ojima T., Nakamura Y., Yanagawa H. A multicenter collaborative study on the risk factors of cardiac sequelae due to Kawasaki disease: a one-year follow-up study. Acta Pediatr. 89:2000;1435-1438.
29. Iemura M., Ishii M., Sugimura T., Akagi T., Kato H. Long term consequences of regressed coronary aneurysms after Kawasaki disease: vascular wall morphology and function. Heart. 83:2000;307-311.
30. Brogan P.A., Bose A., Burgner D., et al. Kawasaki disease: an evidence based approach to diagnosis, treatment, and proposals for future research. Arch Dis Child. 86:2002;286-290.